Weight Loss Patches: What the Law, the FTC and the Labels Say (2026)

Quick answer

As of September 2026, the FDA has approved zero transdermal (skin patch) products for weight management. We checked the openFDA drug label database on September 19, 2026: of the 317 labels with the route "TRANSDERMAL", none is indicated for weight management or obesity. Do weight loss patches work? None of the listings we read states in its product description that the patch causes weight loss, even where the product name says "weight loss": each is marketed as a wellness or botanical product whose own listing says it is not intended to treat any disease, and the FTC's consumer guidance states that nothing you can wear or apply to your skin will cause you to lose weight. The six medicines the FDA has approved for long-term weight management are all prescription-only injections, capsules or tablets.

What the law says a weight loss patch is, and is not

A medicine approved for weight management goes through FDA review before it is sold, and its label is the record of that review. A dietary supplement does not. The FDA's consumer page puts it in capitals: "The FDA does NOT have the authority to approve dietary supplements for safety and effectiveness, or to approve their labeling, before the supplements are sold to the public." Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), firms "are responsible for evaluating the safety and labeling of their products before marketing," and the FDA "has the authority to take action against any adulterated or misbranded dietary supplement product after it reaches the market." Patches add a wrinkle. The federal definition of a dietary supplement at 21 U.S.C. 321(ff) covers a product "intended to supplement the diet" that contains a vitamin, mineral, "herb or other botanical" or similar ingredient and "is intended for ingestion." A patch is worn, not swallowed. One large patch seller says so on its own site: "PatchAid wellness patches are topical wellness products intended solely for general wellness and lifestyle support. They are not medical devices or dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease or medical condition." Either way, no agency reviewed the product's weight claims before it went on sale.

That disclaimer is required, not volunteered. Under 21 CFR 101.93, a supplement making a "structure/function" claim must carry the sentence: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." The sentence, or the asterisk pointing to it, is the product saying in the regulation's own words that it is not a medicine.

What does the FTC say about weight-loss claims for patches?

The FDA regulates what a product is. The Federal Trade Commission regulates advertising, and it has written about patches by name.

The FTC's Health Products Compliance Guidance sets the standard: "claims about the health benefits or safety of foods, dietary supplements, drugs, and other health-related products require substantiation in the form of competent and reliable scientific evidence." The FTC's consumer page on weight loss ads lists the promises it calls false. One is "Lose weight with this patch or cream. (You can't.)" The page also states: "Nothing you can wear or apply to your skin will cause you to lose weight. Period."

The agency has acted on that view. A December 2004 press release titled "FTC: Skin Patches Do Not Cause Weight Loss" describes suits against a patch manufacturer and a retailer alleged to have "falsely claimed that the skin patch causes substantial weight loss," and challenges "false claims that the patch or its main ingredient, sea kelp, has been approved by the Food and Drug Administration." Those are historical cases and say nothing about any product on sale today; what they establish is the rule that a patch advertised as causing weight loss needs competent and reliable scientific evidence behind the claim.

Do weight loss patches work? What the sellers' own listings say

We read the product pages of several patches that rank for this search in September 2026.

PatchAid's Natural Weight Loss Enhancer Patch "combines Vitamin B12, folate, and familiar botanicals in one caffeine-free patch," lists kelp, blue-green algae, bromelain and apple cider vinegar, and says plainly: "This patch won't replace balanced nutrition, movement, or medical care." Its Slim Trim Appetite Support Patch lists lotus leaf, saffron, fucoxanthin, berberine, chromium, green tea and other botanicals, and phrases every benefit as a possibility with an asterisk: "May support normal appetite regulation.*" and "May support normal metabolic function.*"

On Amazon, a listing for Thrivia Berberine Patches for Weight Loss and Metabolic Wellness describes "a thin, stick-on patch format" made with "berberine extract, pomegranate extract, cinnamon extract, and L-glutamine," and states the product has "not been evaluated by the Food and Drug Administration" and "is not intended to diagnose, treat, cure, or prevent any disease." Amazon appends its own line to such listings: "Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition."

To be fair to the sellers: none of the listings we read claims FDA approval, and each uses the hedged language the regulations anticipate. The product names carry the pitch. "Weight loss" appears in the name; "May support normal metabolic function" appears in the fine print. A shopper who reads only the name is buying something the label does not promise.

Can skin deliver a weight-loss ingredient?

Skin patches are real medicine when the molecule fits. The 317 transdermal labels in openFDA show the route works for nicotine, estradiol, testosterone, fentanyl, methylphenidate and scopolamine. The question is whether a weight-management ingredient can cross skin at a useful rate.

A peer-reviewed review in Nature Biotechnology explains the barrier: "The first-generation approach to transdermal delivery is limited primarily by the barrier posed by skin's outermost layer called stratum corneum," and "First-generation delivery candidates must be low-molecular weight, lipophilic and efficacious at low doses." The authors add: "Perhaps the greatest challenge for transdermal delivery is that only a limited number of drugs are amenable to administration by this route."

Botanical extracts are mixtures, not single small molecules. Nothing on the listings we read reports how much of any ingredient crosses skin, and the labels do not claim that any does; the seller has not shown, and is not required to show, that it delivers anything. For peptide medicines the size problem is severe. Our guide to GLP-1 patches and what is actually inside them covers that category in depth; this article does not repeat it.

Which weight-management medicines are FDA-approved, and in what forms?

The NIDDK, part of the National Institutes of Health, introduces its list this way: "The table below lists prescription drugs approved by the FDA for chronic weight management." It names six medicines approved for long-term use: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide and tirzepatide. We read the label the openFDA label API returns for each medicine on September 19, 2026. Every one is a human prescription drug, and not one is a patch.

• Semaglutide (Wegovy) "is indicated in combination with a reduced calorie diet and increased physical activity"; the label openFDA returns describes an injection in pre-filled pens, and the FDA's Drugs@FDA database also lists Wegovy tablets for oral use under application NDA218316, approved December 22, 2025. Neither form is a patch.
• Tirzepatide injection (Zepbound) is indicated "to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition"; an injection in pens and vials.
• Liraglutide injection (Saxenda) is indicated "to reduce excess body weight and maintain weight reduction long term" in patients who meet the label's criteria; an injection in a prefilled pen.
• Phentermine-topiramate (Qsymia): an oral extended-release capsule.
• Naltrexone-bupropion (Contrave): an oral extended-release tablet.
• Orlistat (Xenical): an oral capsule "indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet."

One more label comes up in patch marketing. Semaglutide tablets (Rybelsus, and the tablet form of Ozempic) are indicated "as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus." That is a diabetes indication, not a weight-management approval, and any prescribing decision belongs to a licensed physician. Our explainer on what a GLP-1 medication is covers the class. Our guide to Wegovy alternatives compares the approved options, and our guide to oral and sublingual GLP-1 forms covers non-injection products by label.

Compounded semaglutide and tirzepatide are a separate category. Compounded medications are not FDA-approved as final products. The FDA's compounding page states: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." A compounded medicine still requires a prescription written for you and a licensed pharmacy; see whether compounded semaglutide is FDA-approved and 503A versus 503B pharmacies.

Telling a medicine from a wellness patch: a checklist

Run these checks on any product that puts "weight loss" next to "patch." Each uses a public record.

1. Look for "Rx only." Under 21 U.S.C. 353(b)(4)(A), a prescription drug is misbranded if its label "fails to bear, at a minimum, the symbol 'Rx only'." A product you can add to a cart without a prescription does not carry it.
2. Look for an NDC, and know its limits. Under 21 CFR 207.33 each listed drug "must have a unique NDC to identify its labeler, product, and package size and type." An NDC alone is not approval: the FDA's NDC Directory page says "Assignment of an NDC number does not in any way denote FDA approval of the product."
3. Find the label on DailyMed or openFDA. Prescription labels are submitted to the FDA in the Structured Product Labeling format and published on DailyMed and through the openFDA label API. No label means no FDA-reviewed labeling. Our guide to how to read a prescription label shows what a real one contains.
4. Find the asterisk. A benefit sentence ending in an asterisk that leads to "This statement has not been evaluated by the Food and Drug Administration" is a product telling you it is not a medicine.
5. Ask who prescribed it and who dispensed it. A weight-management medicine reaches you through a prescriber licensed in your state and a pharmacy licensed for your state; the FDA notes that "state boards of pharmacy have primary responsibility for the day-to-day oversight of state-licensed pharmacies." A patch shipped from a marketplace involves neither.
6. Apply the FTC's test to the ad. If the pitch matches one of the FTC's listed false promises, including "Lose weight with this patch or cream," the agency has already said the claim cannot be true as stated.

Are weight loss patches safe? Questions to bring to a physician

No agency reviews a wellness patch for safety before it is sold; the FDA's authority over supplements applies after a product reaches the market. The listings we read disclose botanical ingredients, some of which, such as green tea extract, can contain caffeine. Whether that matters for you is a question for a physician who knows your medications and conditions.

If a patch appealed because injections or pills felt like too much, say so to a physician. Useful questions:

• Am I a candidate for any FDA-approved weight-management medicine, and which forms would be options for me?
• I have been looking at a botanical patch with these ingredients. Do any interact with medicines I take or affect a condition I have?

A physician can say no, and a good one will explain why. Medication is prescribed only if a licensed physician determines it is appropriate.

The bottom line

A weight loss patch is a product the law does not review before sale, in a category the FTC has written about by name, with botanical ingredients whose delivery through skin the seller does not have to demonstrate. The FDA has approved zero transdermal products for weight management as of September 2026. Read the fine print, run the checklist, and put the question of medication to a licensed physician.

This article is for informational purposes only and does not constitute medical advice. Medication is prescribed only if a licensed physician determines it is appropriate. Compounded medications are not FDA-approved as final products. Product descriptions quoted above are the sellers' own words as published on September 19, 2026, and may change.